An Intelligent T1-T2 Switchable MRI Contrast Agent for the Non-Invasive Identification of Vulnerable Atherosclerotic Plaques.
Chunshu Pan,Junjie Lin,Jianjun Zheng,Chuang Liu,Bo Yuan,Ozioma Udochukwu Akakuru,M. Zubair Iqbal,Qianlan Fang,Jiapeng Hu,Jia Chen,Jie Lin,Qi Dai,Xiuyu Guo,Zihou Li,Tao Zhang,Chen Xu,Xuehua Ma,Tianxiang Chen,Aiguo Wu,Yinhua Jin
DOI: https://doi.org/10.1039/d0nr08039j
IF: 6.7
2021-01-01
Nanoscale
Abstract:Unlike stable atherosclerotic plaques, vulnerable plaques are very likely to cause serious cardio-cerebrovascular diseases. Meanwhile, how to non-invasively identify vulnerable plaques at early stages has been an urgent but challenging problem in clinical practices. Here, we propose a macrophage-targeted and in situ stimuli-triggered T1-T2 switchable magnetic resonance imaging (MRI) nanoprobe for the non-invasive diagnosis of vulnerable plaques. Precisely, single-dispersed iron oxide nanoparticles (IONPs) modified with hyaluronic acid (HA), denoted as IONP-HP, show macrophage targetability and T1 MRI enhancement (r2/r1 = 3.415). Triggered by the low pH environment of macrophage lysosomes, the single-dispersed IONP-HP transforms into a cluster analogue, which exhibits T2 MRI enhancement (r2/r1 = 13.326). Furthermore, an in vivo switch of T1-T2 enhancement modes shows that the vulnerable plaques exhibit strong T1 enhancement after intravenous administration of the nanoprobe, followed by a switch to T2 enhancement after 9 h. In contrast, stable plaques show only slight T1 enhancement but without T2 enhancement. It is therefore imperative that the intelligent and novel nanoplatform proposed in this study achieves a substantial non-invasive diagnosis of vulnerable plaques by means of a facile but effective T1-T2 switchable process, which will significantly contribute to the application of materials science in solving clinical problems.